Bioactive Peptides and Proteins: Emerging Trends in Biomedical Sciences
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: closed (20 December 2024) | Viewed by 381
Special Issue Editors
Interests: systems pharmacology; pharmacoinformatics; coputer-aided drug design
Special Issues, Collections and Topics in MDPI journals
Interests: peptide hormones; antimicrobial peptides; fish bioactive peptides
Special Issue Information
Dear Colleagues,
The discovery and design of peptides and proteins have garnered significant interest in the biopharmaceutical field. These molecules exhibit numerous advantages, including antimicrobial, immunomodulatory, antioxidant and anti-inflammatory activities, along with the ability to be engineered for enhanced stability and targeted delivery. The exploration of new sources, rational drug design and advanced techniques in the optimization of peptide and protein structures are driving the development of more efficient and safer bioactive compounds, leading to innovative therapeutic applications for human and animal health.
This Special Issue will explore new sources of and methods for the discovery of bioactive peptides and proteins, develop advanced techniques of rational drug design, optimize peptide and protein structures, enable future advancements in delivery systems for bioactive molecules and evaluate therapeutic applications.
Dr. David Ramirez
Dr. Claudio A. Álvarez
Dr. Paula Andrea Santana
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioactive peptides
- synthetic peptides
- host defense peptides
- peptidomics
- protein engineering
- recombinant proteins
- rational drug design
- drug development strategies
- biopharmaceutical applications
- bioinformatics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
